MRSNMersana Therapeutics Inc
MRSN
Mersana Therapeutics Inc2,847
Mkt Cap
$145.36MVolume
712,460.0052W High
$30.3952W Low
$5.21PE Ratio
-2.06MRSN Fundamentals
Price
$29.08Prev Close
$29.04Open
$28.9050D MA
$24.40Beta
1.87Avg. Volume
76,720.00EPS (Annual)
-$14.12P/B
-2.44Rev/Employee
$397,029.41Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Consensus Rating of "Reduce" from Brokerages
Mersana Therapeutics, Inc. (NASDAQ:MRSN - Get Free Report) has received a consensus rating of "Reduce" from the eight brokerages that are currently covering the stock, Marketbeat Ratings reports. One...
MarketBeat·18d ago
Halper Sadeh LLC Encourages UDMY, ALEX, UBFO, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages UDMY, ALEX, UBFO, MRSN Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages UDMY, ALEX, UBFO, MRSN Shareholders to Contact the Firm to...
PR Newswire·21d ago
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their...
PR Newswire·27d ago
Shareholder Alert: The Ademi Firm continues to investigate whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm continues to investigate whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders Shareholder Alert: The Ademi Firm continues to...
PR Newswire·28d ago
Luminus Management LLC Sells 989,314 Shares of Mersana Therapeutics, Inc. $MRSN
Luminus Management LLC trimmed its stake in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN - Free Report) by 95.2% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·28d ago
683 Capital Management LLC Boosts Stock Position in Mersana Therapeutics, Inc. $MRSN
683 Capital Management LLC lifted its stake in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN - Free Report) by 20.6% in the second quarter, according to the company in its most recent filing with...
MarketBeat·1mo ago
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc...
PR Newswire·1mo ago
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SMLR, MRSN, CDTX, and RYI
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SMLR, MRSN, CDTX, and RYI $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SMLR...
PR Newswire·1mo ago
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of "Reduce" by Brokerages
Mersana Therapeutics, Inc. (NASDAQ:MRSN - Get Free Report) has earned a consensus recommendation of "Reduce" from the eight brokerages that are presently covering the company, Marketbeat Ratings...
MarketBeat·1mo ago
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their...
PR Newswire·2mo ago
<
1
2
...
>